Kaye I Foster Cheek Agios Pharmaceuticals, Inc. (AGIO) insider trading activity

Kaye I Foster Cheek is Director of AGIOS PHARMACEUTICALS, INC.. Currently has a direct ownership of 7,468 shares of AGIO, which is worth approximately $301,333. The most recent transaction as insider was on Jun 20, 2025, when has been sold 2,120 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.47K

39.64% 3M change

39.64% 12M change

Total Value Held $301,333

Kaye I Foster-Cheek Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 20 2025	BUY Exercise of conversion of derivative security	-	2,120 Added 22.11%	7,468 Common Stock
Jun 13 2024	SELL Bona fide gift	-	3,564 Reduced 39.99%	5,348 Common Stock
Jun 13 2024	BUY Exercise of conversion of derivative security	-	3,388 Added 27.54%	8,912 Common Stock
Mar 07 2024	SELL Open market or private sale	$40,631 $31.62 p/Share	1,285 Reduced 18.87%	5,524 Common Stock
Mar 06 2024	SELL Open market or private sale	$141,235 $31.99 p/Share	4,415 Reduced 39.34%	6,809 Common Stock
Mar 05 2024	SELL Open market or private sale	$9,663 $32.21 p/Share	300 Reduced 2.6%	11,224 Common Stock
Aug 09 2023	SELL Open market or private sale	$649,000 $25.96 p/Share	25,000 Reduced 68.45%	11,524 Common Stock
Aug 09 2023	BUY Exercise of conversion of derivative security	$452,250 $18.09 p/Share	25,000 Added 40.63%	36,524 Common Stock
Jun 21 2023	BUY Exercise of conversion of derivative security	-	4,975 Added 30.15%	11,524 Common Stock
Jan 13 2023	SELL Bona fide gift	-	2,200 Reduced 25.15%	6,549 Common Stock
May 20 2022	BUY Exercise of conversion of derivative security	-	1,585 Added 15.34%	8,749 Common Stock
May 28 2021	BUY Exercise of conversion of derivative security	-	1,686 Added 19.05%	7,164 Common Stock

Also insider at

PRME

Prime Medicine, Inc.

Director

KIF